ArticleJournal of virology2000

V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.

A Ly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.